NDC 0517-0735-01 - Nicardipine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0517-0735
- Requested NDC
- 0517-0735-01
- Package NDCs from labels
- 0517-0735-01, 0517-0735-10
- Manufacturer
- American Regent, Inc.
- Effective date
- 2020-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nicardipine Hydrochloride - American Regent, Inc. | American Regent, Inc. | 2020-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0517-0735-01 | Nicardipine Hydrochloride | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 9 | |
| 0517-0735-10 | Nicardipine Hydrochloride | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0517-0735-01 | ML - Milliliter | 0517-0735 | f904440f-8fb1-4fc3-9a34-c1bdf3350710 | 1 | 2020-06-05 |
| 0517-0735-10 | ML - Milliliter | 0517-0735 | 623296fd-3402-4c26-b03a-aaee8e44ebd8 | 1 | 2020-06-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| NICARDIPINE HYDROCHLORIDE | ACTIVE INGREDIENT | K5BC5011K3 | NICARDIPINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 3 | |
| NICARDIPINE | ACTIVE MOIETY | CZ5312222S | NICARDIPINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 3 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | NICARDIPINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NICARDIPINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 3 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | NICARDIPINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| D-99 | ATROPA BELLADONNA, NITROGLYCERIN, LACTIC ACID, UNSPECIFIED FORM, SCROPHULARIA NODOSA, ALOE, RADIUM BROMIDE, POTASSIUM IODIDE, SUS SCROFA BONE MARROW, ZINC, AND CITRIC ACID MONOHYDRATE | DNA Labs, Inc. | dd9c0226-35ea-445a-a570-1ec35551f68d | 2025-01-13 | Warnings | 2968PHW8QP |
| D-97 | ALUMINUM OXIDE, SILVER, SILVER NITRATE, ARSENIC TRIOXIDE, MERCURIUS SOLUBILIS, CALOMEL, MERCURIC IODIDE, LEAD, LEAD IODIDE, CHELIDONIUM MAJUS, ZINC, SOLIDAGO VIRGAUREA FLOWERING TOP, AND CITRIC ACID MONOHYDRATE | DNA Labs, Inc. | b2079abb-786c-4f92-8d49-5606c77f7d72 | 2025-01-13 | Warnings | 2968PHW8QP |
| NICARDIPINE HYDROCHLORIDE | NICARDIPINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 9d898911-d811-2a78-e053-2995a90af784 | 2025-01-08 | Warnings, Adverse reactions | 858607 K5BC5011K3 |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | a480e5f4-5f9e-4b23-b257-b0ac1ebfc115 | 2025-01-07 | Warnings | 506T60A25R |
| Nicardipine Hydrochloride | NICARDIPINE HYDROCHLORIDE | Archis Pharma LLC | d0070638-bea5-413a-8658-4c752c6104f5 | 2024-12-05 | Warnings, Adverse reactions | 858607 K5BC5011K3 |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | ce42122f-8087-471f-b0a3-5524bdbd4526 | 2024-11-19 | Warnings, Adverse reactions | 2968PHW8QP |
| TRICITRATES | POTASSIUM CITRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad | 2024-11-15 | Warnings, Adverse reactions | 2968PHW8QP |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | RB Health Mexico, S.A. de C.V. | 151b9bc9-1a6e-4401-ae58-4b4210ab4505 | 2024-11-15 | Warnings | 2968PHW8QP |
| Nicardipine Hydrochloride | NICARDIPINE HYDROCHLORIDE | Bionpharma Inc. | 7bed5d8c-30c2-4598-acf3-2edba825a56d | 2024-11-04 | Warnings, Adverse reactions | K5BC5011K3 |
| Lungex II | GINKGO BILOBA, COLON (SUIS), LUNG (SUIS), PANCREAS SUIS, GERMANIUM SESQUIOXIDE, CUPRUM METALLICUM, MANGANUM METALLICUM, STANNUM METALLICUM, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALIC ACID, PYRUVIC ACID, SUCCINICUM ACIDUM, NAPHTHOQUINONE, ARSENICUM METALLICUM, CALCAREA CARBONICA, ACONITICUM ACIDUM, CIS, NATRUM OXALACETICUM, PHOSPHORUS | Energique, Inc. | ddf7fc46-95b7-44b4-b7ca-96a066a3fa2b | 2024-10-28 | Warnings | 2968PHW8QP |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | 9aa060f1-f8f6-46e6-a7d0-bd46a73f2676 | 2024-10-17 | Warnings | 506T60A25R |
| Nicardipine hydrochloride | NICARDIPINE | Amneal Pharmaceuticals NY LLC | 79304b0f-53d3-4065-8c81-7031d1141694 | 2024-10-03 | Warnings, Adverse reactions | K5BC5011K3 |
| Nicardipine Hydrochloride | NICARDIPINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 18fb1c2b-0c1e-436c-a5b6-d4840b5da228 | 2024-08-24 | Warnings, Adverse reactions | 858607 K5BC5011K3 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 2968PHW8QP |
| Nicardipine Hydrochloride | NICARDIPINE HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 7226a518-164b-4755-9624-1cc75c939063 | 2024-04-04 | Warnings, Adverse reactions | 858607 K5BC5011K3 |
| Chemtox | BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, HEPAR SUIS, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), ARSENICUM ALBUM, ASARUM CANADENSE, CARBOLICUM ACIDUM, CARBONEUM SULPHURATUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORUS, SELENIUM METALLICUM, SULPHURICUM ACIDUM, CHLORINUM, BUTYLBENZENE, PETROLEUM, SORBITOL | Deseret Biologicals, Inc. | 91f52c95-f36d-4754-8570-f81ed8d36180 | 2024-03-06 | Warnings | 506T60A25R |
| Nicardipine Hydrochloride | NICARDIPINE HYDROCHLORIDE | Epic Pharma, LLC | b8f147b8-955f-4733-9178-2cfa0beb60d6 | 2023-12-27 | Warnings, Adverse reactions | K5BC5011K3 |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| NICARDIPINE HYDROCHLORIDE | NICARDIPINE HYDROCHLORIDE | Burel Pharmaceuticals, LLC | cb902af0-b5ad-4680-b2f2-007ef2196efe | 2023-09-07 | Warnings, Adverse reactions | K5BC5011K3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.